for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Telix Pharma Receives US FDA Feedback On Phase 3 Trial Design For Prostate Cancer Therapy Product

July 8 (Reuters) - Telix Pharmaceuticals Ltd:

* RECEIVES US FDA FEEDBACK ON PHASE 3 TRIAL DESIGN FOR PROSTATE CANCER THERAPY PRODUCT

* INTENDS TO FILE A PHASE 3 IND FOR TLX591 PRIOR TO END OF 2020 Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up